ISGylation regulates lung endothelial inflammation
ISGylation 调节肺内皮炎症
基本信息
- 批准号:10180376
- 负责人:
- 金额:$ 58.82万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-04-20 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:Acute Lung InjuryAdult Respiratory Distress SyndromeAnti-Inflammatory AgentsCell Adhesion MoleculesCell physiologyDataDevelopmentDiseaseEndothelial CellsEndotheliumExhibitsF-Box ProteinsFamily memberFoundationsFunctional disorderGenesGenetic TranscriptionHumanIL8 geneISG15 geneImmune responseInflammationInflammatoryIntercellular adhesion molecule 1InterferonsInterleukin-6LeadLigaseLungMediatingModificationMolecularNF-kappa BNF1 geneNuclearPathogenesisPathologicPathway interactionsPhosphoric Monoester HydrolasesPhosphorylationPlayPost-Translational Protein ProcessingProcessPropertyProteinsRegulationReportingRestRoleSchemeSepsisSerineSeveritiesSiteStimulusStructure of parenchyma of lungTranscriptional ActivationTransgenic MiceUbiquitin Like ProteinsUp-Regulationattenuationchemokineendothelial dysfunctionisopeptidaselung injurymouse modelneutrophilnovel therapeuticsoverexpressionp65responseside effectsmall moleculesmall molecule inhibitortranscription factorubiquitin-protein ligase
项目摘要
Abstract
Excessive lung microvascular endothelial inflammation is a pathological hallmark of acute
respiratory distress syndrome (ARDS). Upon inflammatory stimuli, lung endothelial cells (ECs)
increase chemokine and adhesion molecule expression, such as IL-6, and intercellular adhesion
molecule 1, ultimately causing neutrophil accumulation at the site of inflammation, endothelial
barrier dysfunction, and lung tissue damage in acute lung injury and sepsis. Nuclear
transcriptional factor κB (NF-κB) plays a pivotal role in EC inflammation. Inflammatory stimuli
trigger phosphorylation of NF-κB component p65, leading to increase p65 transcriptional activity.
We revealed that NF-κBp65 can be ISGylated. The ISGylated p65 is inactive in the resting ECs.
We also discovered that SCFFBXL19 E3 ligase catalyzes ISGylation of p65, impedes p65
phosphorylation, and mitigates lung EC inflammation. These observations led us to hypothesize
that p65 ISGylation by SCFFBXL19 dampens its phosphorylation, transcriptional activation, and lung
EC inflammation; and increases in FBXL19 stability mitigates lung EC inflammation through
reducing NF-kB activation. To better understand the new modification of p65, in this proposal, we
will determine molecular mechanisms by which SCFFBXL19 catalyzes p65 ISGylation and its role in
human lung microvascular EC inflammation. And then, we will determine the molecular
mechanisms by which p65 ISGylation impedes its phosphorylation and activation in human lung
microvascular ECs. Lastly, we will determine if stabilization of FBXL19 alleviates lung EC
inflammation in murine models of acute lung injury and sepsis. This application will be the first to
characterize SCFFBXL19-mediated ISGylation of NF-κBp65 and determine its role in the regulation
of p65 phosphorylation, transcriptional activation, and lung EC inflammation in acute lung injury
and sepsis.
抽象的
过度的肺微血管内皮炎症是急性肺损伤的病理标志。
呼吸窘迫综合征(ARDS)在炎症刺激下,肺内皮细胞(EC)。
增加趋化因子和粘附分子的表达,例如 IL-6 和细胞间粘附
分子1,最终导致中性粒细胞在炎症、内皮部位积聚
屏障功能障碍以及急性肺损伤和脓毒症中的肺组织损伤。
转录因子 κB (NF-κB) 在 EC 炎症刺激中发挥着关键作用。
触发 NF-κB 成分 p65 的磷酸化,导致 p65 转录活性增加。
我们发现 NF-κBp65 可以被 ISG 化,ISG 化的 p65 在静息 EC 中处于非活性状态。
我们还发现 SCFFBXL19 E3 连接酶催化 p65 的 ISGylation,阻碍 p65
这些观察结果引导我们进行战斗。
SCFFBXL19 的 p65 ISGylation 抑制其磷酸化、转录激活和肺功能
EC 炎症;FBXL19 稳定性的增加可通过以下方式减轻肺部 EC 炎症:
减少 NF-kB 激活 为了更好地理解 p65 的新修饰,在这个提案中,我们
将确定 SCFFBXL19 催化 p65 ISGylation 的分子机制及其在
然后,我们将确定人肺微血管EC炎症。
p65 ISGylation 阻碍其在人肺中磷酸化和激活的机制
最后,我们将确定 FBXL19 的稳定是否会减轻肺 EC。
急性肺损伤和脓毒症小鼠模型中的炎症该应用将是第一个。
表征 SCFFBXL19 介导的 NF-κBp65 ISGylation 并确定其在调节中的作用
急性肺损伤中 p65 磷酸化、转录激活和肺 EC 炎症的影响
和败血症。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Yutong Zhao其他文献
Yutong Zhao的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Yutong Zhao', 18)}}的其他基金
Molecular regulation of BMPRII stability in lung fibrosis
肺纤维化中 BMPRII 稳定性的分子调节
- 批准号:
10712273 - 财政年份:2023
- 资助金额:
$ 58.82万 - 项目类别:
ISGylation regulates lung endothelial inflammation
ISGylation 调节肺内皮炎症
- 批准号:
10614448 - 财政年份:2021
- 资助金额:
$ 58.82万 - 项目类别:
ISGylation regulates lung endothelial inflammation
ISGylation 调节肺内皮炎症
- 批准号:
10394303 - 财政年份:2021
- 资助金额:
$ 58.82万 - 项目类别:
Regulation of proteolysis by deubiquiting enzyme in lung inflammatory disease
肺部炎症疾病中去泛素化酶对蛋白水解的调节
- 批准号:
9912813 - 财政年份:2018
- 资助金额:
$ 58.82万 - 项目类别:
Molecular regulation of anti-inflammatory cytokine receptor in sepsis
脓毒症抗炎细胞因子受体的分子调控
- 批准号:
9912821 - 财政年份:2018
- 资助金额:
$ 58.82万 - 项目类别:
Regulation of proteolysis by deubiquiting enzyme in lung inflammatory disease
肺部炎症疾病中去泛素化酶对蛋白水解的调节
- 批准号:
9237362 - 财政年份:2017
- 资助金额:
$ 58.82万 - 项目类别:
Regulation of the IL-33 receptor, ST2L, by Protein Stability in Septic Injury
脓毒性损伤中蛋白质稳定性对 IL-33 受体 ST2L 的调节
- 批准号:
8666032 - 财政年份:2013
- 资助金额:
$ 58.82万 - 项目类别:
Regulation of the IL-33 receptor, ST2L, by Protein Stability in Septic Injury
脓毒性损伤中蛋白质稳定性对 IL-33 受体 ST2L 的调节
- 批准号:
8499556 - 财政年份:2013
- 资助金额:
$ 58.82万 - 项目类别:
Regulation of the IL-33 receptor, ST2L, by Protein Stability in Septic Injury
脓毒性损伤中蛋白质稳定性对 IL-33 受体 ST2L 的调节
- 批准号:
8851660 - 财政年份:2013
- 资助金额:
$ 58.82万 - 项目类别:
Regulation of the IL-33 receptor, ST2L, by Protein Stability in Septic Injury
脓毒性损伤中蛋白质稳定性对 IL-33 受体 ST2L 的调节
- 批准号:
9067468 - 财政年份:2013
- 资助金额:
$ 58.82万 - 项目类别:
相似国自然基金
肺撞击伤的生物力学机理及其并发ARDS的病理机制研究
- 批准号:39370670
- 批准年份:1993
- 资助金额:5.3 万元
- 项目类别:面上项目
刺激性气体致成人呼吸窘迫综合征的机理及诊断防治研究
- 批准号:39270582
- 批准年份:1992
- 资助金额:4.0 万元
- 项目类别:面上项目
相似海外基金
Cellular and molecular mechanisms of alveolar repair
肺泡修复的细胞和分子机制
- 批准号:
10750085 - 财政年份:2023
- 资助金额:
$ 58.82万 - 项目类别:
Immune, hormonal, and muscle mitochondrial determinants of recovery in Acute Respiratory Distress Syndrome survivors
急性呼吸窘迫综合征幸存者康复的免疫、激素和肌肉线粒体决定因素
- 批准号:
10659639 - 财政年份:2023
- 资助金额:
$ 58.82万 - 项目类别:
Impact of Aging on Oxysterol Regulation of Alveolar Macrophage Function during S. pneumoniae
衰老对肺炎链球菌期间肺泡巨噬细胞功能的氧甾醇调节的影响
- 批准号:
10737015 - 财政年份:2023
- 资助金额:
$ 58.82万 - 项目类别:
Neuroendocrine control of TLR4-dependent inflammation in influenza
流感中 TLR4 依赖性炎症的神经内分泌控制
- 批准号:
10193411 - 财政年份:2021
- 资助金额:
$ 58.82万 - 项目类别:
Mechanisms of exacerbation of COVID-19 pathogenesis in mice expressing human ACE2 by polycyclic aromatic hydrocarbons (PAHs), and its protection by inhibition of soluble epoxide hydrolase (sEH)
多环芳烃 (PAH) 表达人 ACE2 的小鼠中 COVID-19 发病机制恶化,以及通过抑制可溶性环氧化物水解酶 (sEH) 对其进行保护
- 批准号:
10337295 - 财政年份:2021
- 资助金额:
$ 58.82万 - 项目类别: